Michael Noble

1.0k total citations
55 papers, 680 citations indexed

About

Michael Noble is a scholar working on Infectious Diseases, Clinical Biochemistry and Epidemiology. According to data from OpenAlex, Michael Noble has authored 55 papers receiving a total of 680 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 10 papers in Clinical Biochemistry and 8 papers in Epidemiology. Recurrent topics in Michael Noble's work include Bacterial Identification and Susceptibility Testing (9 papers), Antimicrobial Resistance in Staphylococcus (7 papers) and Clinical Laboratory Practices and Quality Control (7 papers). Michael Noble is often cited by papers focused on Bacterial Identification and Susceptibility Testing (9 papers), Antimicrobial Resistance in Staphylococcus (7 papers) and Clinical Laboratory Practices and Quality Control (7 papers). Michael Noble collaborates with scholars based in Canada, United Kingdom and United States. Michael Noble's co-authors include Thomas J. Marrie, J. W. Costerton, Hugh James Freeman, E. V. Haldane, D. Gareth Evans, H. Lior, David J. Evans, Lawrence S. Young, David P. Speert and Rajagopal Subramaniam and has published in prestigious journals such as Nature, SHILAP Revista de lepidopterología and Clinical Infectious Diseases.

In The Last Decade

Michael Noble

53 papers receiving 618 citations

Peers

Countries citing papers authored by Michael Noble

Since Specialization

Citations

This map shows the geographic impact of Michael Noble's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Noble with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Noble more than expected).

Fields of papers citing papers by Michael Noble

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Noble. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Noble. The network helps show where Michael Noble may publish in the future.

Co-authorship network of co-authors of Michael Noble

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Noble. A scholar is included among the top collaborators of Michael Noble based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Noble. Michael Noble is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Improving drinking water quality through proficiency testing—the impact of testing method and accreditation status on Escherichia coli detection by Canadian environmental testing laboratories 2024 ·Frontiers in Molecular Biosciences ·(unknown), (unknown), (unknown), Caleb Lee, (unknown), (unknown), Michael Noble, Lucy A. Perrone	0
2	Ensuring diagnostic testing accuracy for patient care and public health- COVID-19 testing scale-up from an EQA provider’s perspective 2023 ·SHILAP Revista de lepidopterología ·(unknown), Selvarani Vimalanathan, (unknown), Michael Noble, Lucy A. Perrone	1
3	Strengthening the clinical laboratory workforce in Cambodia: a case study of a mixed-method in-service training program to improve laboratory quality management system oversight 2020 ·Human Resources for Health ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Michael Noble, Lucy A. Perrone	3
4	Laboratory error reporting rates can change significantly with year-over-year examination 2018 ·Diagnosis ·Michael Noble, (unknown), A. E. Taylor, D. Douglas Cochrane	2
5	Combined international external quality assessment results of medical laboratory performance and reporting of samples with known antimicrobial resistance 2018 ·Diagnosis ·Michael Noble, Robert Rennie	0
6	Medical laboratory associated errors: the 33-month experience of an on-line volunteer Canadian province wide error reporting system 2017 ·Diagnosis ·(unknown), A. E. Taylor, D. Douglas Cochrane, Michael Noble	11
7	Performance of Canadian clinical laboratories processing throat culture proficiency testing surveys 2014 ·Accreditation and Quality Assurance ·(unknown), (unknown), Caleb Lee, (unknown), Michael Noble	1
8	Healthcare-associated infection and the patient experience: a qualitative study using patient interviews 2009 ·Journal of Hospital Infection ·Emma Burnett, (unknown), Rosemary Rushmer, Mark Ellis, Michael Noble, Peter Davey	35
9	A Study of the Pharmacokinetic Profile of Low-Dose Hepatitis B Immune Globulin in Long-Term Liver Transplant Recipients for Chronic Hepatitis B Infection 2001 ·American Journal of Transplantation ·Nilufar Partovi, (unknown), Mary H. H. Ensom, Michael Noble, Eric M. Yoshida	8
10	An interprovincial external quality assessment of the ability of Canadian laboratories to detect the vancomycin and penicillin resistance of Enterococcus faecium D366 1999 ·Clinical Microbiology and Infection ·Harold Richardson, Michael Noble, Christine Fleming, (unknown), Alexander MacKenzie	2
11	The toilet as a transmission vector of vancomycin-resistant enterococci 1998 ·Journal of Hospital Infection ·Michael Noble, Judith L. Isaac‐Renton, Elizabeth Bryce, D. Roscoe, F. J. Roberts, Mary E. Walker, (unknown), Anne Walsh, Manuel Altamirano-Dimas, Marie J. Gribble	33
12	Microbial population balancing as a quantitative aid for evaluating release from a high pressure homogenizer 1995 ·Process Safety and Environmental Protection ·(unknown), Eli Keshavarz‐Moore, (unknown), Michael Noble, (unknown)	1
13	Xanthomonas maltophilia Misidentified as Pseudomonas cepacia in Cultures of Sputum from Patients with Cystic Fibrosis: A Diagnostic Pitfall with Major Clinical Implications 1995 ·Clinical Infectious Diseases ·David R. Burdge, Michael Noble, M E Campbell, (unknown), David P. Speert	40
14	Sharps utilization and disposal in British Columbia physicians' offices. 1993 ·PubMed ·Rusung Tan, Michael Noble	5
15	Enzyme Rate Assay for 5-Fluorocytosine 1993 ·American Journal of Clinical Pathology ·(unknown), (unknown), Michael Noble	1
16	Arcanobacterium hemolyticum infection: Confused with scarlet fever and diphtheria 1991 ·Journal of Emergency Medicine ·Kevin C. Kain, Michael Noble, (unknown), (unknown)	8
17	Spontaneous Yersinia enterocolitica Septicemia in a Patient with Iron Overload 1990 ·Canadian Journal of Infectious Diseases and Medical Microbiology ·(unknown), Michael Noble, Terence G. Sparling	2
18	Characterization of a Neutrophil-Inhibitory Factor from Clinically Significant Staphylococcus epidermidis 1990 ·The Journal of Infectious Diseases ·Michael Noble, (unknown), (unknown)	8
19	Marketing Programs at Colleges and Universities: A Progress Report. 1986 ·College and university ·Michael Noble	5
20	Latex agglutination test to identify coagulase, clumping factor and protein A produced by staphylococci. 1983 ·PubMed ·(unknown), Robert Bortolussi, Michael Noble	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact